Health
Recurrent GBM brain tumors with few mutations respond best to immunotherapy – Duke Department of Neurology
Glioblastoma brain tumors are especially perplexing.
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after theyve grown back, enabling up to 20% of patients to live well beyond predicted survival times.
What causes this effect has long been the pursuit of researchers hoping to harness immunotherapies to extend more lives.
New insights from a team led by Dukes Preston Robert Tisch Brain Tumor Center, including the Neurology Department’s Katherine Peters, MD, PhD, Dina Randazzo,…
-
General20 hours agoFirefighter suffers ‘potentially life-threatening injuries’ in truck crash at Mundoolun, south of Brisbane
-
Noosa News23 hours agoTwo people charged after Mooloolaba stabbing
-
Business19 hours agoWhich is the only ASX 200 bank stock Macquarie expects to outperform in FY 2026?
-
Business21 hours agoUp 99% in a year, guess which ASX 300 stock is rocketing higher again today